|
"yj chen"的相關文件
顯示項目 26-35 / 73 (共8頁) << < 1 2 3 4 5 6 7 8 > >> 每頁顯示[10|25|50]項目
| 臺北醫學大學 |
2014 |
Non-standard dose dronedarone in treating atrial fibrillation patients
|
JH, Huang;YK, Lin;MH, Hsieh;SA, Chen;YJ, Chen |
| 臺北醫學大學 |
2014 |
Leisure-time physical activity and neuropsychiatric symptoms of community-dwelling persons with cognitive impairment
|
YC, Chiu;AM, Kolanowski;CY, Huang;LJ, Lin;TH, Chang;KH, Hsu;CJ, Hu;YJ, Chen |
| 臺北醫學大學 |
2014 |
Leisure-time physical activity and neuropsychiatric symptoms of community-dwelling persons with cognitive impairment
|
YC, Chiu;AM, Kolanowski;CY, Huang;LJ, Lin;TH, Chang;KH, Hsu;CJ, Hu;YJ, Chen |
| 臺北醫學大學 |
2014 |
Modeling pegylated liposomal doxorubicin-induced hand-foot syndrome and intestinal mucositis in zebrafish
|
YH, Chen;YT, Lee;CC, Wen;YC, Chen;YJ, Chen |
| 臺北醫學大學 |
2014 |
Expression of WW domain-containing oxidoreductase WOX1 in human nervous system tumors
|
MF, Chiang;ST, Chen;CP, Lo;CI, Sze;NS, Chang;YJ, Chen |
| 臺北醫學大學 |
2014 |
FGF-23 dysregulates calcium homeostasis and electrophysiological properties in HL-1 atrial cells
|
Kao, YH;Chen, YC;Lin, YK;Shiu, RJ;Chao, TF;Chen, SA;YJ*, ?Chen |
| 臺北醫學大學 |
2014 |
Cardiac metabolism, inflammation, and peroxisome proliferator-activated receptors modulated by 1,25-dihydroxyvitamin D3 in diabetic rats
|
Lee, TI;YH*, Kao;Chen, YC;Tsai, WC;Chung, CC;YJ*, Chen |
| 臺北醫學大學 |
2014 |
Androgen attenuates cardiac fibroblasts activations through modulations of transforming growth factor-β and angiotensin II signaling
|
Chung, CC;Hsu, RC;YH*, Kao;Liou, JP;Lu, YY;YJ*, Chen |
| 臺北醫學大學 |
2014 |
Testosterone replacement increases aged pulmonary vein and left atrium arrhythmogenesis with enhanced adrenergic activity
|
Tsai, WC;Lee, TI;Chen, YC;Kao, YH;Lu, YY;Lin, YK;Chen, SA;YJ*, ?Chen |
| 臺北醫學大學 |
2014 |
Electromechanical Effects of 1,25-Dihydroxyvitamin D with Antiatrial Fibrillation Activities
|
Hanafy, DA;Chang, SL;Lu, YY;Chen, YC;Kao, YH;Huang, JH;Chen, SA;YJ*, ?Chen |
顯示項目 26-35 / 73 (共8頁) << < 1 2 3 4 5 6 7 8 > >> 每頁顯示[10|25|50]項目
|